Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Zaremba Rabourn Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Apr 27, 2026.
On the most recent filing, Zaremba Rabourn Amy is listed as Head of Fin. Quality Assurance at Opus Genetics, Inc. Inside the rolling window, Zaremba Rabourn Amy reported no open-market purchases and 2 open-market sales totaling $23K in IRD. The largest disclosed transaction in the window is a sale of 2,816 IRD shares on Mar 16, 2026, worth $15K.
Companies traded
Other insiders at IRD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$23K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Zaremba Rabourn Amy made?
Zaremba Rabourn Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Zaremba Rabourn Amy trade?
Zaremba Rabourn Amy has filed SEC Form 4 disclosures for 1 company, including IRD.
When was Zaremba Rabourn Amy's most recent SEC Form 4 filing?
Zaremba Rabourn Amy's most recent SEC Form 4 filing on Tracefour is dated Apr 27, 2026.
What is Zaremba Rabourn Amy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Zaremba Rabourn Amy is listed as Head of Fin. Quality Assurance.
What is Zaremba Rabourn Amy's total buy and sell value in the current window?
Inside the rolling retention window, Zaremba Rabourn Amy bought $0 and sold $23K based on SEC Form 4 filings.
What was Zaremba Rabourn Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,816 IRD shares on 2026-03-16, worth $15K, per SEC Form 4 filings.